By American Heart Association News
Testing blood for a biological marker called suPAR could help better assess the risk of death among African-Americans with Type 2 diabetes, according to a new study.
SuPAR, or soluble urokinase plasminogen activator receptor, is a protein marker that indicates inflammation in the blood. Scientists have used suPAR to help assess the severity of various conditions, particularly kidney disease but also HIV, cancer and other illnesses.
While elevated suPAR levels have been associated with higher risk of death among people with those diseases, it previously had not been examined closely among those with Type 2 diabetes, a major risk factor for both heart and kidney disease.